Founded in 2005, Korea Institute for Pharmaceutical Policy Affairs, KIPPA, is a non-profit, public foundation, approved by the Korean Ministry of Health and Welfare. The institute is contributed by three relevant parties, the Korean Pharmaceutical Association (KPA), the Korea Pharmaceutical and Bio-Pharma Manufacturers Association (KBPMA), and the Korea Pharmaceutical Distribution Association (KPDA).

KIPPA is a leading research center, which aims to promote public health through the development of policy regarding the rational use of medicines, pharmacy education, pharmacy practice, pharmaceutical industry, and pharmaceutical supply and distribution. In particular, we begin to develop ¡®a community pharmacy model as a health promotion center for community members¡¯. We are collecting and analysing big data accordingly to develop pharmacy-based policies, which pursue maximised pharmacy practice for all the Koreans.

In consequence, KIPPA will consistently implement research tailored to the promotion of health in the nation and worldwide. We kindly ask for supports from our fellow pharmacists, public and associations.

If you have any further enquiries about the institute or research in English, please contact us via e-mail (kippa.org@gmail.com).

Thank you.

Office Address
3FL, 194, Hyoryeong-ro, Seocho-gu, Seoul, Repbulic of Korea

ÇöÀçÀ§Ä¡ : Home : ¾Ë¸²¸¶´ç : ¿¬±¸¼Ò ´º½º
   
¾Ë¸²¸¶´ç
°øÁö»çÇ×
º¸µµÀÚ·á
ÀÎÀçä¿ë
 
 
Á¦   ¸ñ [´ëÇѾà»çÀú³Î]'ºÒºÐ¸í'ÇÑ °ü¸® ºÎó, ¹ý·ü¡¤±ÔÁ¦ Á¶Ç× 'Àü¹«'
³»   ¿ë

'ºÒºÐ¸í'ÇÑ °ü¸® ºÎó, ¹ý·ü¡¤±ÔÁ¦ Á¶Ç× 'Àü¹«'

µ¿¹°ÀÇ ÀÎüÀǾàǰ »ç¿ë¿¡ ´ëÇÑ ±¹³»¿Ü ¹ý·É ºñ±³ <5>


º» °í¿¡¼­´Â Áö³­ 2020³â 2¿ù ¹ß°£µÈ 'ÀǾàǰÁ¤Ã¥¿¬±¸' 14±Ç 2È£ [ƯÁý] ÁÖÁ¦¿´´ø µ¿¹°ÀǾàǰ °ü¸® ÇöȲ°ú °ü·ÃÇØ ½Ç¸° <µ¿¹°ÀÇ ÀÎüÀǾàǰ »ç¿ë¿¡ ´ëÇÑ ±¹³»¿Ü ¹ý·É ºñ±³> ¿ø°í¸¦ ¿øÀúÀÚÀÇ ½ÂÀÎÀ» ¹Þ¾Æ, ÀǾàǰÁ¤Ã¥¿¬±¸¼Ò ¸®Æ÷Æ® ÇмúÁö¸éÀ» ÅëÇØ Àç¼Ò°³ÇϰíÀÚ ÇÑ´Ù. 'ÀǾàǰÁ¤Ã¥¿¬±¸'´Â ÀǾàǰ °³¹ß, »ý»ê, À¯Åë ¹× »ç¿ë°ú °ü·ÃµÈ Á¤Ã¥Àû À̽´¸¦ ±íÀÌ ÀÖ°Ô ¿¬±¸, ºÐ¼®ÇØ ÇÕ¸®ÀûÀΠÁ¤Ã¥À» Á¦½ÃÇϰíÀÚ 2006³â Ã¢°£µÈ ÀÌ·¡ ¿¬ 2ȸ ²ÙÁØÈ÷ ¹ßÇàµÇ°í Àִ Á¤±â°£Ç๰ÀÌ´Ù. [ÆíÁýÀÚ ÁÖ]


<Áö³­È£¿¡ À̾>
¥³. ³ª°¡¸ç
ÇöÀ砹ݷÁµ¿¹°¿¡ »ç¿ëÇϰí Àִ ÀǾàǰÀÇ 70% Á¤µµ°¡ ÀÎü¿ë ÀǾàǰÀ¸·Î ÀÌ·ç¾îÁ® ÀÖ´Ù. ±× ÀÌÀ¯´Â ´Ù¾çÇÑ Á¾, ¼Ò¼ö »ý»êÀ¸·Î ÀÎÇÑ °æÁ¦¼º ¶§¹®¿¡ µ¿¹°ÀǾàǰÀÇ Á¾·ù°¡ ¸¹Áö ¾Ê±â ¶§¹®Àε¥, ÀÌ·¯ÇÑ ÀÌÀ¯·Î Çؿܠ¸¹Àº ±¹°¡µéµµ µ¿¹°¿¡ ÀÎüÀǾàǰ »ç¿ëÀ» Çã¿ëÇϰí ÀÖ´Ù. 

±×·¯³ª ¹Ì±¹ÀÇ °æ¿ì¿£, ¡®µ¿¹°ÀÇ °Ç°­ÀÌ À§ÇùÀ» ¹Þ°Å³ª Ä¡·á ½ÇÆÐ·Î °íÅ렶Ǵ »ç¸ÁÀÌ ÃÊ·¡ µÉ ¼ö ÀÖÀ» ¶§¡¯ ¼öÀÇ»çÀÇ ÀÎüÀǾàǰ »ç¿ëÀ» Çã¿ëÇϰí ÀÖ°í, ¿µ±¹ÀÇ °æ¿ì¿£ ¡®µ¿¹°ÀÇ ¼ö¿ë ºÒ°¡´ÉÇÑ °íÅëÀ» ÇÇÇϱâ À§ÇØ ¿µ±¹¿¡ Àΰ¡µÈ µ¿¹°ÀǾàǰÀÌ ¾øÀ» °æ¿ì¡¯ ´Ü°èÀûÀ¸·Î »ç¿ëÀÌ °¡´ÉÇÏ´Ù.
 
´ºÁú·£µåÀÇ °æ¿ìµµ ¸¶Âù°¡Áö·Î »ç¿ëÇÒ ¼ö Àִ Çã°¡µÈ µ¿¹° ÀǾàǰÀÌ ¾øÀ» ¶§ »ç¿ëÇϵµ·Ï Çã¿ëÇϰí ÀÖ´Ù. 

±×·¯³ª ±¹³» ¼öÀÇ»çÀÇ ÀÎüÀǾàǰ »ç¿ëÀº ¾à»ç¹ý ³»¿¡ ¾à±¹°³¼³ÀڷκÎÅÍ ÀÎü¿ë Àü¹®ÀǾàǰ ±¸ÀÔÀÌ °¡´ÉÇϵµ·Ï µÅ ÀÖ´Ù. »ç½Ç»ó µ¿¹°¿¡°Ô ÀÎüÀǾàǰ »ç¿ëÀ» Çã¿ëÇϰí ÀÖÀ¸³ª µ¿¹°ÀÇ ÀÎüÀǾàǰ »ç¿ë¿¡ ´ëÇÑ Á¶°ÇÀ» ¸í½ÃÇÑ Á¶Ç×Àº ¾ø´Ù. 

ÀϺ»ÀÇ °æ¿ìµµ ¸¶Âù°¡Áö·Î ¼öÀÇ»çÀÇ ÀÎüÀǾàǰ »ç¿ëÀÌ °¡´ÉÇÑ ¹ý·üÁ¶Ç×Àº ÀÖÀ¸³ª º°µµÀÇ »ç¿ëÁ¶°ÇÀ» ±ÔÁ¤ÇÏÁö´Â ¾Ê°í ÀÖ´Ù.

¼öÀÇ»çÀÇ µ¿¹°¿¡ ´ëÇÑ ÀÎüÀǾàǰ Ã³¹æÀº ¿ì¸®³ª¶ó¸¦ Á¦¿ÜÇÑ 4°³±¹ ¸ðµÎ Çã¿ëÇϴ ¹ý·üÁ¶Ç×ÀÌ ÀÖ¾úÀ¸¸ç, ¼öÀÇ»ç Ã³¹æ¿¡ µû¸¥ ¾à»çÀÇ Á¶Á¦µµ Çã¿ëÇϰí ÀÖ¾ú´Ù. 

µ¿¹°ÀǠƯ¼ö¼º ¶§¹®¿¡ ¼öÀÇ»çÀÇ Á÷Á¢ Á¶Á¦¸¦ Çã¿ëÇϰí ÀÖÁö¸¸, ¶ÇÇÑ ¼öÀÇ»çÀÇ ÀÎüÀǾàǰ Ã³¹æ°ú ¾à»çÀÇ Á¶Á¦µµ Çã¿ëÇϴ ¹ý·ü°ú Á¤Ã¥À» Ã¤ÅÃÇϰí ÀÖ¾ú´Ù. 

¹Ý¸é¿¡ ¿ì¸®³ª¶ó´Â ¼öÀÇ»çÀÇ ÀÎüÀǾàǰ Ã³¹æ°ú ¾à»çÀÇ µ¿¹°¿¡ ´ëÇÑ ÀÎüÀǾàǰ Á¶Á¦¿¡ ´ëÇØ º°µµ·Î ±ÔÁ¤ÇÑ ¹ý·ü Á¶Ç×ÀÌ ¾ø´Ù. 

¼öÀÇ»çÀÇ ÀÎüÀǾàǰ »ç¿ë¿¡ ´ëÇÑ ±ÔÁ¦ ÀåÄ¡µµ ¾øÀ» »Ó¸¸ ¾Æ´Ï¶ó, °ü¸®Çϴ ºÎóµµ ºÒºÐ¸íÇÑ »óÅÂÀÌ´Ù. 

¹ý·É°ú ±ÔÁ¦°¡ Àü¹«ÇÏ´Ùº¸´Ï ¼öÀÇ»çÀÇ ÀÎüÀǾàǰ »ç¿ëÀº ¾î¶² Á¾·ùÀÇ ÀǾàǰÀÌ ¾î´À Á¤µµ·Î, ¾î¶»°Ô ¾²À̰í ÀÖ´ÂÁö ¾Ë ¼ö°¡ ¾ø´Ù.

2017³â 12¿ù ³ó¸²Ãà»ê½ÄǰºÎ°¡ Àü±¹ÀûÀ¸·Î ½ÃÇàÇÑ µ¿¹°º´¿øÀÇ ÀÎüÀǾàǰ »ç¿ë ÇöȲ »ùÇÃÁ¶»ç¿¡ µû¸£¸é ¾à±¹¿¡¼­ ¿À³²¿ëÀǾàǰÀ¸·Î ÁöÁ¤µÅ °ü¸®°¡ µÇ°í Àִ ¼ººÐÀÇ ÀǾàǰÀÌ ½ÇÁ¦ »ç¿ëÀÌ µÇ°í ÀÖ¾ú°í, 1¼¼´ë¡­3¼¼´ë ¼¼ÆÄ°è Ç×»ýÁ¦µµ »ç¿ëÀÌ µÇ°í ÀÖ¾ú´Ù. 

ÀÌ·¯ÇÑ ÀÎü¿ë ÀǾàǰµéÀÇ ¿À³²¿ëÀ» ¸·±â À§Çؼ­´Â µ¿¹°¿¡ ´ëÇØ ÀûÀýÇÑ ÀÎüÀǾàǰ »ç¿ë Á¶°ÇÀ» ±ÔÁ¤Çϴ °ÍÀÌ ÇÊ¿äÇÏ´Ù. 

¶ÇÇÑ, ¼öÀǻ簡 »ç¶÷ÀÌ ¾Æ´Ñ µ¿¹°¿¡¸¸ Á¦ÇÑÀûÀ¸·Î ÀÎüÀǾàǰ Ã³¹æÀüÀ» ¹ß±ÞÇϴ ¹®Á¦¿¡ ´ëÇØ¼­µµ ¹ý·É º¸¿Ï°ú ´õºÒ¾î ÁßÀå±âÀûÀ¸·Î °ËÅäÇØ ºÁ¾ß ÇÑ´Ù. 

±×¸®°í ¼öÀǻ簡 »ç¿ëÇϴ ÀÎüÀǾàǰ¿¡ ´ëÇØ¼­´Â º°µµÀÇ º¸°í½Ã½ºÅÛÀ» ¸¸µé¾î °ü¸®Çϴ °ÍÀÌ ÇÊ¿äÇÏ´Ù.

Á¤ÇÑÃáÀÇ µ¿¹°¾àǰ ºÐ¾÷¿¡ ´ëÇÑ ´çÀ§¼º¿¡ °üÇÑ ¿¬±¸(2003)¿¡¼­´Â µ¿¹°¾àǰ ºÐ¾÷ÀÇ ´çÀ§¼ºÀº ÀÎÁ¤µÇ³ª ¼öÀÇ»çÀÇ ¼ö, Ãà»ê¾÷ÀÇ °æÀï·Â ¾àÈ­ µîÀÇ ¹®Á¦Á¡À¸·Î ÀǾàºÐ¾÷º¸´Ù´Â ¿äÁÖÀÇ ¼ººÐ µî¿¡ ´ëÇÑ ±ÔÁ¦¿Í °ü¸®¡¤°¨µ¶ °­È­¸¦ ÅëÇØ µ¿¹°¾àǰÀÇ ¿À³²¿ëÀ» ¹æÁöÇØ¾ß ÇÑ´Ù°í Çß´Ù. 

¶ÇÇÑ, ÀÎÀûÀÚ¿øÀÌ ºÎÁ·ÇÑ ½ÃÁ¡¿¡¼­´Â µ¿¹°ÀÇ ÀǾàºÐ¾÷ÀÌ ¾à»ç³ª ¼öÀÇ»çÀÇ ¿ì¿ùÀûÀÌ°í µ¶Á¡Àû ÁöÀ§¸¸À» º¸ÀåÇØÁ־ҺñÀÚÀÇ Ãß°¡ ºñ¿ë°ú ºÒÆíÀÌ Áõ´ëµÈ´Ù°í Çß´Ù. 

¼öÀÇ»ç Ã³¹æÁ¦¸¦ ´Ù·é ¿¬±¸·Î´Â ¡®¼öÀÇ»ç Ã³¹æÁ¦ ½ÃÇà ÈÄ ÀνĠÇöȲ ¹× °³¼± ¹æ¾È¡¯(°­º´±¸, 2018)°ú ¡®µ¿¹°¾à±¹ÀÇ ÀνĠÇöȲ ¹× ¾à»çÀÇ µ¿¹°¿ë ÀǾàǰ ±³À°ÀÇ Çʿ伺¡¯(ÀÌ¿µ¾Æ, 2014)ÀÌ ÀÖÀ¸¸ç, µ¿¹°¿¡ ´ëÇÑ ÀǾàǰ »ç¿ë¿¡ À־ »ç¶÷ ÀÇ·áü°è¿Í °°Àº ÀǾàºÐ¾÷ µµÀÔÀÇ Çʿ伺°ú ±×¿¡ ´ëÇÑ ¾à»çÀÇ ±³À°ÀÌ ÇÊ¿äÇÏ´Ù°í Çß´Ù.

µ¿¹°¿¡ »ç¿ëÇϴ ÀǾàǰ°ú °ü·ÃµÈ ¹ý·É°ú ±ÔÁ¦ µî¿¡ °üÇÑ ±¹³» ¿¬±¸·Î´Â ¡®°¢±¹ÀÇ µ¿¹°¿ëÀǾàǰ °ü¸®Á¦µµ ¹× Á¶Á÷ü°è ºñ±³¡¯(È«±â¼º, 2006)°¡ Àִµ¥, µ¿¹°ÀǾàǰÀÇ ¾ÈÀüÇÑ °ü¸®¸¦ À§Çؼ­´Â µ¿¹°ÀǾàǰ °ü¸®¹ý Á¦Á¤À» ÅëÇØ ÀûÀýÇÑ °ü¸®Ã¼°è ±¸ÃàÀÌ ÇÊ¿äÇÏ´Ù°í Çß´Ù. 

¡®µ¿¹°¿ëÀǾàǰ ¹× ÀǾà¿Üǰ µîÀÇ °ü¸®¿¡ °üÇÑ ¹ý±Ô °³¼±¹æ¾È ¿¬±¸¡¯(½ÄǰÀǾàǰ ¾ÈÀüó, 2017)¿¡¼­´Â µ¿¹°ÀǾàǰÀÇ ¹üÀ§µµ »ê¾÷µ¿¹°¿ë°ú ¹Ý·Áµ¿¹°¿ëÀ¸·Î ³ª´©¾î °¢±â »ç¿ë °¡´ÉÇÑ ÀǾàǰ¿¡ ´ëÇØ ±ÔÁ¦¸¦ µû·Î ÁøÇàÇϴ °ÍÀÌ ¹Ù¶÷Á÷Çϰí, ÀÜ·ù°ü¸®¿Í µ¿¹°¿ëÀǾàǰ¿¡ ´ëÇÑ ¹ý·ü ±Ù°Åµµ °­È­ÇؾߠÇÑ´Ù°í Çß´Ù. 

¶ÇÇÑ ÇöÀçÀÇ ¾à»ç¹ý ½Ã½ºÅÛ ¾È¿¡¼­´Â ¹ý·ü ³» ¹ý·ÉÀ» Ãß°¡Çϱâ´Â ½±Áö ¾Ê±â ¶§¹®¿¡ µ¿¹°¿ë ÀǾàǰ ¹ýÀ» ½Å¼³Çϴ ¹æÇâÀ» Á¦¾ðÇϰí ÀÖ´Ù.

ÀÌ·¯ÇÑ ±âÁ¸ÀÇ ¿¬±¸´Â ´ëºÎºÐ µ¿¹°¿¡ »ç¿ëÇϴ µ¿¹°¿ëÀǾàǰ¿¡ ´ëÇÑ ¿¬±¸·Î¼­ µ¿¹°¿¡ »ç¿ëÇϴ ÀÎü¿ëÀǾàǰ¿¡ ´ëÇØ¼­´Â ÀÚ¼¼È÷ ´Ù·çÁö ¾Ê¾Ò´Ù. 

¿ì¸®³ª¶ó´Â ÀǾàºÐ¾÷ ÀÌÈÄ, ÀÎüÀǾàǰÀ» µ¿¹°¿¡ »ç¿ëÇϴ ÀýÂ÷¿Í ¹æ½ÄÀÌ Á¦´ë·Î Á¤ºñµÇÁö ¾Ê¾Æ ±ÔÁ¤»ó ¹ÌÈíÇÑ ºÎºÐÀÌ ÀÖ°í, ¼öÀÇ»ç¹ý°ú ¾à»ç¹ý »óÈ£ °£¿¡µµ ¼öÀÇ»çÀÇ ÀÎüÀǾàǰ »ç¿ë °ü·Ã ±ÔÁ¤µéÀÌ ÇØ¼®»ó ³í¶õÀÇ ¼ÒÁö°¡ ÀÖ´Ù. 

¶ÇÇÑ, ¼öÀÇ»çÀÇ ÀÎüÀǾàǰ »ç¿ë¿¡ ´ëÇÑ °ü¸®ºÎó°¡ º°µµ·Î ¾ø¾î µ¿¹°º´¿ø¿¡ ÀÎüÀǾàǰÀ» À¯ÅëÇϴ °úÁ¤¿¡¼­ ¿À³²¿ëµÉ ¿©Áö°¡ ÀÖ°í, ¼ÒºñÀÚÀÇ °æÁ¦Àû ºÎ´ã ¶ÇÇÑ Å« °ÍÀ¸·Î ¾Ë·ÁÁ® ÀÖÀ¸¸ç, ¼öÀÇ»ç¿Í ¾à»ç °£ ¿µ¿ª °¥µîÀ» Á¶ÀåÇϰí Àִ »óȲÀÌ´Ù.

µû¶ó¼­ ÀÎüÀǾàǰÀ» µ¿¹°¿¡°Ô »ç¿ëÇÔ¿¡ ÀÖ¾î Àü¹®°¡ÀΠ¼öÀÇ»ç¿Í ¾à»çÀÇ ¿ªÇÒÀ» ºÐ¸íÈ÷ ÇØ ÀǾàǰ ¿À³²¿ë ¹× À¯Åë Áú¼­ À§¹Ý ¼ÒÁö¸¦ ¾ø¾Öµµ·Ï ¹ýÀûÀ¸·Î º¸¿ÏÇØ ³ª°¡¾ß ÇÒ Çʿ䰡 ÀÖ´Ù. 



Âü°í¹®Çå
1) ¾à»ç°ø·Ð, µ¿¹°º´¿ø 99% Ã³¹æÀü ¹ßÇà Àü¹«, ¼öÀǻ砵¶Á¡Á¦ º¯Áú ¿ì·Á, 2016.12.29.
2) ¾à¾÷½Å¹®, °³ Á¾ÇÕ¹é½Å Ã³¹æÀü ¹ßÇà µ¿¹°º´¿ø 4õ¿© °÷ Áß 16°÷ ºÒ°ú, 2016.12.29.
3) µ¥Àϸ®ºª, ºÒ¹ý¿¡ ³»¸ô¸®´Â µ¿¹°º´¿ø¡¦´ë¹ý, ÀÎü¿ëÀǾàǰ ¹è¼ÛÆÇ¸Å À§¹ý, 2017.1.20.
4) µ¿¾ÆÀϺ¸. ¼öÀÇ»çµéµµ ÀǾàºÐ¾÷ ¡®ºÒ¶Ë¡¯¡¦ÀÎü¿ë ¾àǰ ±¸ÀÔ ¸øÇØ, 2000.7.19.


¹ÚÁö¿µ°æ±âµµ¾à»çȸµ¿¹°¾àǰÀ§¿øÀå


[±â»çÃâó] https://www.kpanews.co.kr/academy/show.asp?page=1&search_cate=8&idx=363

 

¹øÈ£ ÷ºÎ Á¦¸ñ ÀÛ¼ºÀÚ ÀÛ¼ºÀÏ Á¶È¸
92 [¸ÞµðÆÄ³ª´º½º]'Äڷγª19 ´ëÀÀ¡¤ÅëÇÕµ¹º½' ´Ù·é ÀǾàǰÁ¤Ã¥¿¬±¸ ¹ß°£  ±è¼±Èñ 2021-01-19 4
91 [¾à»ç°ø·Ð] ¾à±¹ °ÅÁ¡ Àڻ쿹¹æ»ç¾÷, »ý¸íÁöÅ´ÀÌ ¿ªÇÒ 'ÅåÅå'  ±è¼±Èñ 2021-01-19 3
90 [µ¥Àϸ®ÆÊ] ÀϺ»¾à±¹ÀÇ ÁøÈ­¡¦Ä«µå·Î 'Áߺ¹Åõ¾à¡¤³²Àº ¾à °ü¸®±îÁö'  ±è¼±Èñ 2021-01-19 6
89 [´ëÇѾà»çÀú³Î] ¼¼ÀÌÇÁ¾à±¹¡¤¹æ¹®¾à·á µî Ȱµ¿ Áö¼Ó Áõ°¡  ÀÌÁö¿¬ 2021-01-19 3
88 [´ëÇѾà»çÀú³Î] ¾à±¹ ó¹æÁýÁßµµ º¯È­¿Í ¾à±¹¾à»çÀÇ »çȸÀû ¿ªÇÒ Ãß±¸ ÀÌÁö¿¬ 2021-01-13 45
87 [´ëÇѾà»çÀú³Î] ÀåÁ¡Àº Ű¿ì°í ´ÜÁ¡Àº ¾ø¾Ö´Â ±³À°¹æ¹ýÀº? ÀÌÁö¿¬ 2021-01-06 77
86 [´ëÇѾà»çÀú³Î] 'Àڱ⠹ݿµ ¾ç½Ä' ÅëÇØ ¾à±¹ Àü¹®°¡ ±âÁØ ÆÄ¾Ç ÀÌÁö¿¬ 2020-12-29 81
85 [´ëÇѾà»çÀú³Î] CPD °³³ä µîÀå 80³â, ¿ì¸®³ª¶ó´Â ¾ÆÁ÷¡¦ ÀÌÁö¿¬ 2020-12-22 92
84 ¹Ì±¹¡¤¿µ±¹ ¾à»ç, ¿Â¶óÀÎÀ¸·Î ¾î¶»°Ô °øºÎÇϳª ±è¼±Èñ 2020-12-16 95
83 ÀǾàǰÁ¤Ã¥¿¬ "¿Â¶óÀÎ ¿¬¼ö±³À°¿¡ CPD µµÀÔÇØ¾ß" ±è¼±Èñ 2020-12-16 89
82 [´ëÇѾà»çÀú³Î] CPD °³³ä µîÀå 80³â, ¿ì¸®³ª¶ó´Â ¾ÆÁ÷¡¦ ÀÌÁö¿¬ 2020-12-16 77
81 [´ëÇѾà»çÀú³Î] Áö¿ª ¿©°Ç ¸ÂÃá 'Ä¡¸Å¾È½É¸¶À»'+'Ä¡¸Å¾È½É¾à±¹' ¿î¿µ ÀÌÁö¿¬ 2020-12-08 98
80 [´ëÇѾà»çÀú³Î] È£ÁÖ ¾à±¹ÀÇ Ä¡¸Å Äɾî Àü·«Àº? ÀÌÁö¿¬ 2020-12-01 109
79 [¾à»ç°ø·Ð] Ä¡¸Å±¹°¡Ã¥ÀÓÁ¦ '¿Ö ¾à»ç´Â ºüÁ³À»±î'¡¦¿Ü±¹Àº ¾î¶»°Ô? ±è¼±Èñ 2020-11-25 129
78 [µ¥Àϸ®ÆÊ] ³â µÚ Ä¡¸ÅÀα¸ 100¸¸ ½Ã´ë¡¦¾à±¹ ¿ªÇÒÀ» ã¾Æ¶ó ±è¼±Èñ 2020-11-25 130

ÀÌÀü 10ÆäÀÌÁö [1]  [2]  [3]  [4]  [5]  [6]  [7]  ´ÙÀ½ 10ÆäÀÌÁö

 
 

¼­¿ï ¼­Ãʱ¸ È¿·É·Î194, 3Ãþ (Àç)ÀǾàǰÁ¤Ã¥¿¬±¸¼Ò TEL : 02) 3474-5301 / FAX : 02)3474-5306

COPYRIGHT (C) 2006 KOREA INSTITUTE FOR PHARMACEUTICAL POLICY AFFAIRS ALL RIGHTS RESERVED. FOR MORE INFORMATION MAL kippa.org@gmail.com

±âºÎ±Ý ¾È³»